Product Information
ZOLPIDEM TARTRATE 10 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.0396 per EA under NDC 00781531810. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 23, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Sandoz Inc.NDC
00781531810
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077322FDA Approved
4/23/2007
TE Code
AB
On Market Since
4/23/2007
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TARTRATE 10 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 57.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0396 per EA |
|---|---|
| All-time high | $0.0400 (Jan 10, 2024) |
| All-time low | $0.0227 (Aug 19, 2015) |
| 52-week high | $0.0396 |
| 52-week low | $0.0377 |
| Median price | $0.0316 |
| Average price | $0.0319 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolpidem Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid A Receptor Positive Modulator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLPIDEM TARTRATE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TARTRATE 10 MG TABLET, manufactured by Sandoz Inc., is $0.0396 per EA (NDC 00781531810), effective Sep 30, 2026.
How has the price of ZOLPIDEM TARTRATE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TARTRATE 10 MG TABLET has risen 57.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TARTRATE 10 MG TABLET?
Since Nov 28, 2013, the NADAC for ZOLPIDEM TARTRATE 10 MG TABLET has ranged from a low of $0.0227 (Aug 19, 2015) to a high of $0.0400 (Jan 10, 2024), with a median of $0.0316 per EA.
Are there cheaper alternatives to ZOLPIDEM TARTRATE 10 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLPIDEM TARTRATE 10 MG TABLET, is $0.0271 per EA — about 32% below ZOLPIDEM TARTRATE 10 MG TABLET.
Who manufactures ZOLPIDEM TARTRATE 10 MG TABLET?
ZOLPIDEM TARTRATE 10 MG TABLET (NDC 00781531810) is labeled by Sandoz Inc., and CMS classifies it as a generic product.